Results 161 to 170 of about 21,238,241 (185)
Some of the next articles are maybe not open access.

CYFRA21-1 can predict the sensitivity to chemoradiotherapy of non-small-cell lung carcinoma

Biomarkers, 2010
The increasing panel of systemic therapies enables the individual management of lung cancer patients, even in advanced stages. However, predictive tools indicating the efficacy of chemoradiotherapy (CRT) are badly needed.To determine the tumour markers for predicting the therapeutic effect in non-small-cell lung carcinoma (NSCLC) patients treated with ...
Juan, Wang   +6 more
openaire   +2 more sources

SERUM CYTOKERATIN-19 MEASURED BY CYFRA21-1 ASSAY IN PATIENTS WITH GASTROINTESTINAL AND GYNECOLOGIC MALIGNANCY

International Journal of Oncology, 1994
The serum fragment of cytokeratin 19 was measured in 130 patients with gastrointestinal, breast and gynecologic cancer and 62 patients with benign disease using CYFRA21-1 immunoradiometric assay. Patients with advanced cancer showed the highest level of serum CYFRA21-1.
H, Sakahara   +6 more
openaire   +2 more sources

Combination of serum miRNAs with Cyfra21-1 for the diagnosis of non-small cell lung cancer

Cancer Letters, 2015
In this study, we screened 381 miRNAs by RT-qPCR in serum samples of 44 NSCLC patients and 22 healthy individuals to identify altered miRNAs, and validated the results in a training and test cohorts with 300 serum samples (178 NSCLC and 122 healthy individuals).
Chengcheng, Zhou   +9 more
openaire   +2 more sources

[Diagnostic value of combined detection of CYFRA21-1 and TSGF in nasopharyngeal carcinoma].

Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology, 2006
To study the diagnostic value of cytokeraetin 19 fragment (CYFRA21-1) and tumor supplied group factors (TSGF) in nasopharyngeal carcinoma (NPC).Serum levels of CYFRA21-1 and TSGF in 82 patients with NPC, 25 patients with benign nasopharyngeal disease and 50 normal controls were measured by electrochemiluminescence immuno-assay.The levels of CYFRA21-1 ...
Lingsha, Huang   +2 more
openaire   +1 more source

[Evaluation of a cytokeratin 19 assay kit "BALL ELSA CYFRA21-1"].

Kaku igaku. The Japanese journal of nuclear medicine, 1994
We evaluated "BALL ELSA CYFRA21-1" kit, an immunoradiometric assay kit for cytokeratin 19. Monoclonal antibodies KS19-1 and BM19-21 are used for immunoadsorbent and indicator, respectively. There was no problems in reproducibility, dilution test and recovery test. Minimum detectable concentration was 0.42 ng/ml.
H, Sakahara   +7 more
openaire   +1 more source

[Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer].

Zhonghua zhong liu za zhi [Chinese journal of oncology], 2004
To study the clinical significance of serum CEA, SCC and Cyfra21-1 test in the diagnosis, prediction of prognosis and postoperative monitor of recurrence in esophageal cancer.The concentration of serum CEA and Cyfra21-1 was measured by electrochemiluminescence immunoassay (ECLIA) using Elecsys 2010, CEA kit and Cyfra21-1 kit.
You-sheng, Mao   +5 more
openaire   +1 more source

The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience.

Anticancer research, 1999
There are a wide variety of tumor markers now available that proved to be of value in the management of cancer patients. Of these markers, tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) are well known in the field of bladder cancer.
O, el-Ahmady, A B, Halim, A G, el-Din
openaire   +1 more source

Sensitive detection of CYFRA21-1 by a controlled release sensor based on personal glucose meter

Sensors and Actuators B: Chemical, 2022
Hongmin Ma, Lihua Hu, Qin Wei
exaly  

Home - About - Disclaimer - Privacy